{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:29:39Z","timestamp":1779244179073,"version":"3.51.4"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T00:00:00Z","timestamp":1339718400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0038589","type":"journal-article","created":{"date-parts":[[2012,6,16]],"date-time":"2012-06-16T04:20:53Z","timestamp":1339820453000},"page":"e38589","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Real-Time Monitoring of Tumorigenesis, Dissemination, &amp; Drug Response in a Preclinical Model of Lymphangioleiomyomatosis\/Tuberous Sclerosis Complex"],"prefix":"10.1371","volume":"7","author":[{"given":"Fangbing","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine P.","family":"Lunsford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingli","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitomo","family":"Ashitate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Summer L.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hak Soo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth P.","family":"Henske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John V.","family":"Frangioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,6,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex.","volume":"355","author":"PB Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1165\/rcmb.2006-0372TR","article-title":"Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans.","volume":"36","author":"SC Juvet","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0030-1269906","article-title":"Tuberous sclerosis complex: neurological, renal and pulmonary manifestations.","volume":"41","author":"DN Franz","year":"2010","journal-title":"Neuropediatric"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/ajrccm.164.4.2101154","article-title":"Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex.","volume":"164","author":"J Moss","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1196\/annals.1413.018","article-title":"Lymphatic involvement in lymphangioleiomyomatosis.","volume":"1131","author":"CG Glasgow","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/lrb.2009.0028","article-title":"The International LAM Registry: a component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform.","volume":"8","author":"M Nurok","year":"2010","journal-title":"Lymphat Res Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1086\/301804","article-title":"Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.","volume":"62","author":"TA Smolarek","year":"1998","journal-title":"Am J Hum Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.","volume":"97","author":"T Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1164\/ajrccm.163.1.2005004","article-title":"The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis.","volume":"163","author":"GD Strizheva","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.","volume":"99","author":"AR Tee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0898-6568(03)00040-8","article-title":"Tumour suppressors hamartin and tuberin: intracellular signalling.","volume":"15","author":"VP Krymskaya","year":"2003","journal-title":"Cell Signal"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1101\/gad.995802","article-title":"Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1\/eIF4E.","volume":"16","author":"DC Fingar","year":"2002","journal-title":"Genes Dev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.98.1.136","article-title":"A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt.","volume":"98","author":"M Aoki","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signalling controls tumour cell growth.","volume":"441","author":"RJ Shaw","year":"2006","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.molcel.2010.05.007","article-title":"Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply.","volume":"38","author":"AY Choo","year":"2010","journal-title":"Mol Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma.","volume":"68","author":"AG Knudson Jr","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01366952","article-title":"Hereditary cancer: two hits revisited.","volume":"122","author":"AG Knudson","year":"1996","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1369\/jhc.4A6438.2004","article-title":"Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis.","volume":"52","author":"X Zhe","year":"2004","journal-title":"J Histochem Cytochem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/gcc.10252","article-title":"Metastasis of benign tumor cells in tuberous sclerosis complex.","volume":"38","author":"EP Henske","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1038\/sj.onc.1209090","article-title":"Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.","volume":"24","author":"A Astrinidis","year":"2005","journal-title":"Oncogene"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1165\/rcmb.2005-0374OC","article-title":"Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis.","volume":"34","author":"EA Goncharova","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)61720-8","article-title":"The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms.","volume":"159","author":"JL Arbiser","year":"2001","journal-title":"Am J Pathol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0002-9440(10)61198-4","article-title":"Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor.","volume":"167","author":"E Lesma","year":"2005","journal-title":"Am J Pathol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.2353\/ajpath.2009.080799","article-title":"The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells.","volume":"174","author":"E Lesma","year":"2009","journal-title":"Am J Pathol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/lrb.2009.0031","article-title":"Lymphangioleiomyomatosis and TSC2\u2212\/\u2212 cells.","volume":"8","author":"TN Darling","year":"2010","journal-title":"Lymphat Res Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1530\/eje.0.1440297","article-title":"Na(+)\/I(-) symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues.","volume":"144","author":"L Lacroix","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1530\/eje.0.1410382","article-title":"Immunohistochemical analysis of Na+\/I- symporter distribution in human extra-thyroidal tissues.","volume":"141","author":"L Vayre","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.semnuclmed.2003.09.004","article-title":"The Na\/I symporter (NIS): imaging and therapeutic applications.","volume":"34","author":"E Dadachova","year":"2004","journal-title":"Semin Nucl Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.cgt.7700661","article-title":"Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography.","volume":"11","author":"DK Marsee","year":"2004","journal-title":"Cancer Gene Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"L694","DOI":"10.1152\/ajplung.00204.2003","article-title":"Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways.","volume":"286","author":"J Yu","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.molcel.2008.04.027","article-title":"mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation.","volume":"30","author":"F Hong","year":"2008","journal-title":"Mol Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1479-5876-8-14","article-title":"Comparison of three rapamycin dosing schedules in A\/J Tsc2+\/\u2212 mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors.","volume":"8","author":"C Woodrum","year":"2010","journal-title":"J Transl Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/1097-0142(19830901)52:5<851::AID-CNCR2820520518>3.0.CO;2-M","article-title":"Pulmonary lymphangioleiomyomatosis and Bourneville&apos;s tuberous sclerosis with pulmonary involvement: the same disease?","volume":"52","author":"F Capron","year":"1983","journal-title":"Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/1097-0142(196612)19:12<1909::AID-CNCR2820191219>3.0.CO;2-R","article-title":"Lymphangiomyoma, a benign lesion of chyliferous lymphatics synonymous with lymphangiopericytoma.","volume":"19","author":"JL Cornog Jr","year":"1966","journal-title":"Cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1158\/0008-5472.CAN-04-3840","article-title":"Estrogen enhances whereas tamoxifen retards development of Tsc mouse liver hemangioma: a tumor related to renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.","volume":"65","author":"N El-Hashemite","year":"2005","journal-title":"Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1158\/1535-7163.MCT-09-0055","article-title":"Renal and liver tumors in Tsc2(+\/\u2212) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.","volume":"8","author":"GA Finlay","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref37","first-page":"245","article-title":"Tuberin-heterozygous cell line TSC2ang1 as a model for tuberous sclerosis-associated skin lesions.","volume":"21","author":"PK Wlodarski","year":"2008","journal-title":"Int J Mol Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/lrb.2009.0013","article-title":"Animal models of lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC).","volume":"8","author":"DJ Kwiatkowski","year":"2010","journal-title":"Lymphat Res Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e3558","DOI":"10.1371\/journal.pone.0003558","article-title":"Anti-EGFR antibody efficiently and specifically inhibits human TSC2\u2212\/\u2212 smooth muscle cell proliferation. Possible treatment options for TSC and LAM.","volume":"3","author":"E Lesma","year":"2008","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/gcc.10281","article-title":"Uterine leiomyoma in the Eker rat: a unique model for important diseases of women.","volume":"38","author":"CL Walker","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1073\/pnas.0810790106","article-title":"Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells.","volume":"106","author":"JJ Yu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","first-page":"234","article-title":"Crawford HC, Matrisian LM (1994\u20131995) Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.","volume":"14","journal-title":"Invasion Metastasis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5858\/2000-124-0267-RFAOMM","article-title":"Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis.","volume":"124","author":"K Matsui","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc863","article-title":"Lymphangiogenesis and cancer metastasis.","volume":"2","author":"SA Stacker","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/84635","article-title":"VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.","volume":"7","author":"SA Stacker","year":"2001","journal-title":"Nat Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/lrb.2009.0020","article-title":"mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the &quot;perfect storm&quot; of pro-metastatic factors in LAM pathogenesis.","volume":"8","author":"J Yu","year":"2010","journal-title":"Lymphat Res Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.","volume":"363","author":"DA Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.","volume":"358","author":"JJ Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis.","volume":"364","author":"FX McCormack","year":"2011","journal-title":"N Engl J Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0038589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T05:36:55Z","timestamp":1642484215000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0038589"}},"subtitle":[],"editor":[{"given":"Salvatore V.","family":"Pizzo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,15]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0038589","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,15]]}}}